Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × padeliporfin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Transitional Cell Cancer of Renal Pelvis and Ureter 1

Interventions

Specimen Handling 294 pembrolizumab 259 Magnetic Resonance Spectroscopy 241 Carboplatin 170 Biopsy 156 Cyclophosphamide 140 Cisplatin 139 Paclitaxel 115 Radiotherapy 109 Bevacizumab 104 Gemcitabine 103 Nivolumab 95 venetoclax 94 Dexamethasone 89 fludarabine 84 Fluorouracil 72 Rituximab 71 Docetaxel 69 Oxaliplatin 68 Pemetrexed 67 Drug Therapy 67 Capecitabine 65 Standard of Care 62 Radiosurgery 60 durvalumab 58 Radiation 58 Injections 57 atezolizumab 56 X-Rays 56 Leucovorin 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04620239 2026-02-04

UCM301

Steba Biotech S.A.

Phase 3 Recruiting

Transitional Cell Cancer of Renal Pelvis and Ureter

Data powered by HemOnc (CC BY 4.0) Colophon ⚡